As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Moderna: Toronto Dominion Bank, CTC LLC, GTS Securities LLC, Arrowpoint Investment Partners Singapore Pte. Ltd., Wolverine Trading LLC, Squarepoint Ops LLC, Tidal Investments LLC, Sig Brokerage LP, Royal Bank of Canada, Millennium Management LLC, Moore Capital Management LP, LMR Partners LLP, Jefferies Financial Group Inc., Group One Trading LLC, Eisler Capital Management Ltd., Farallon Capital Management LLC, D. E. Shaw & Co. Inc., Cubist Systematic Strategies LLC, Caption Management LLC, Capstone Investment Advisors LLC, Citadel Advisors LLC, Balyasny Asset Management L.P., BNP Paribas Financial Markets, Jane Street Group LLC, Tudor Investment Corp ET AL, Boothbay Fund Management LLC, CMT Capital Markets Trading GmbH, Parallax Volatility Advisers L.P., Two Sigma Securities LLC, Susquehanna International Group LLP, Concourse Financial Group Securities Inc., PEAK6 LLC, Walleye Trading LLC, Walleye Capital LLC, Warberg Asset Management LLC, Capital Fund Management S.A., Bank of Nova Scotia, One River Asset Management LLC, JPMorgan Chase & Co., Mirae Asset Securities USA Inc., Twin Tree Management LP, Marathon Trading Investment Management LLC, Garda Capital Partners LP, Union Bancaire Privee UBP SA, Game Plan Financial Advisors LLC, XY Capital Ltd, IMC Chicago LLC, Caas Capital Management LP, Union Bancaire Privee UBP SA, FNY Investment Advisers LLC, and JPMorgan Chase & Co.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.